ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,301.60
-0.15%
S&P ASX All Technology
3,882.40
0.49%
Brent Oil
72.985
-0.16%
US Dollar vs AUD
1.5818
0.26%
Bitcoin
104,675.68
-1.39%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. N4 Pharma Plc (N4P) Share Price

N4 Pharma Plc

N4 Pharma Plc (N4P)

LSE
0.575
-0.025
(-4.17%)
Closed 18 December 3:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.575
Bid
0.55
Offer
0.60
Volume
796,089
0.575 Day's Range 0.60
0.412 52 Week Range 1.40
Market Cap
2.27M
Previous Close
0.60
Open
0.60
Last Trade
9233
@
0.55
(O)
Last Trade Time
Financial Volume
4,777p
VWAP
0.60
Average Volume (3m)
1,496,882
Shares Outstanding
394,780,000
Dividend Yield
-
PE Ratio
-1.78
Earnings Per Share (EPS)
-0
Revenue
2k
Net Profit
-1.27M

About N4 Pharma Plc

Sector
Drug & Proprietary Stores
Industry
Computer & Office Equipment
Website
www.n4pharma.com
Headquarters
Derbyshire, Gbr
Founded
1990
N4 Pharma Plc is listed in the Drug & Proprietary Stores sector of the London Stock Exchange with ticker N4P. The last closing price for N4 Pharma was 0.60p. Over the last year, N4 Pharma shares have traded in a share price range of 0.412p to 1.40p.

N4 Pharma currently has 394,780,000 shares in issue. The market capitalisation of N4 Pharma is £2.37 million. N4 Pharma has a price to earnings ratio (PE ratio) of -1.78.

Ask ADVFN Intelligence (AI)

N4P Latest News

More News

N4 Pharma PLC N4 101 In Vitro Results

N4 Pharma PLC 12 December 2024   12 December 2024 N4 Pharma plc ("N4 Pharma" or the "Company")   N4 101 in vitro Results Latest data demonstrate key benefits of the Nuvec® delivery platform  ...

12 December 2024
RNS Regulatory News

N4 Pharma PLC New Patent Filing

N4 Pharma PLC 04 December 2024   4 December 2024 N4 Pharma plc ("N4 Pharma" or the "Company")   New Patent Filing   N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing...

04 December 2024
RNS Regulatory News

N4 Pharma PLC Grant of Options

N4 Pharma PLC 28 November 2024     28 November 2024   N4 Pharma plc ("N4 Pharma" or the "Company")   Grant of Options   N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company...

28 November 2024
RNS Regulatory News

N4 Pharma PLC N4 Pharma CEO Q&A Now LIVE

N4 Pharma PLC 01 November 2024     N4 Pharma plc  ("N4 Pharma" or the "Company")   N4 Pharma CEO Q&A Now LIVE   N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing...

01 November 2024
RNS Non-Regulatory

N4 Pharma PLC New Corporate Presentation

N4 Pharma PLC 24 October 2024     N4 Pharma plc  ("N4 Pharma" or the "Company")   New Corporate Presentation and CEO Q&A   N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company...

24 October 2024
RNS Non-Regulatory

EARNINGS: Metals One advances Black Schist, N4 generates revenue

The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by ...

25 September 2024
Alliance News

N4 Pharma PLC Interim Results

N4 Pharma PLC 24 September 2024    24 September 2024 N4 Pharma Plc ("N4 Pharma" or the "Company") Interim Results N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing...

24 September 2024
RNS Regulatory News

N4 Pharma PLC SRI Research Update

N4 Pharma PLC 17 September 2024   17 September 2024 N4 Pharma plc ("N4 Pharma" or the "Company")   SRI Research Update   N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company...

17 September 2024
RNS Regulatory News

N4 Pharma PLC Director Appointment

N4 Pharma PLC 09 September 2024   9 September 2024 N4 Pharma plc ("N4 Pharma" or the "Company")   Director Appointment   N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company...

09 September 2024
RNS Regulatory News

N4 Pharma PLC Change of Auditor

N4 Pharma PLC 23 August 2024   23 August 2024 N4 Pharma plc ("N4 Pharma" or the "Company")   Change of Auditor   N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing...

23 August 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0254.545454545450.550.60.5256036030.5827401DE
4-0.075-11.53846153850.650.6750.5256430510.58174531DE
120.0254.545454545450.550.750.52514968820.63225429DE
260.075150.50.750.41212323650.58624384DE
52-0.225-28.1250.81.40.41212463170.75134311DE
156-4.675-89.04761904765.255.250.4129419011.55172102DE
260-2.325-80.17241379312.915.50.41214701555.77097522DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TM1Technology Minerals Plc
0.265p
(140.91%)
635.73M
HUMHummingbird Resources Plc
2.30p
(39.39%)
8.51M
QEDQuadrise Plc
6.00p
(29.03%)
28.48M
LPALpa Group Plc
72.00p
(26.32%)
63.26k
DARDar Global Plc
US$ 6.00
(22.45%)
16.75k
APIAbrdn Property Income Trust Limited
9.51p
(-84.36%)
13.57M
KDNCCadence Minerals Plc
1.65p
(-40.00%)
17.87M
BLUBlue Star Capital Plc
0.015p
(-25.00%)
18.2M
SYMESupply@me Capital Plc
0.0034p
(-22.73%)
1.43B
SCGLSealand Capital Galaxy Limited
1.40p
(-22.22%)
6.15M
NTVONativo Resources Plc
0.0021p
(-12.50%)
4.78B
SYMESupply@me Capital Plc
0.0034p
(-22.73%)
1.43B
TRPTower Resources Plc
0.031p
(8.77%)
637.54M
TM1Technology Minerals Plc
0.265p
(140.91%)
635.73M
ORCPOracle Power Plc
0.026p
(-3.70%)
340.06M

Discussion

View Full Feed
KILLAZILLA KILLAZILLA 1 minute ago
NOT NECESSARY. CALLING OTHERS "JERKS" MAKES you the " KEYBOARD A$$ HOLLE" AROUND HERE!!!
XERI
Dead On Arrival Dead On Arrival 2 minutes ago
The dollar valuation is killing my investment on the US side.
GCUMF
uber darthium uber darthium 2 minutes ago
Yes, because of the significant costs involved with filings each quarter and the continual obligation to all of the regulatory issues of staying current on the OTCMarkets.

He already has received all of the assets and what is left now is a revoked former company, no longer public.
Chipaway Chipaway 2 minutes ago
Up a Whopping 36% today on VERY HIGH Volume. We have a long way to go to get to the Target Price of $45. Still time to get in low.
NRXP
Whalatane Whalatane 2 minutes ago
Raggy ...U are making to much $ elsewhere ...I'm thinking of banning U from this board :--)
Congrats on your AI / Quantum picks
I'm in PLTR and SOUN .....but QUBT , QBTS , RGTI ...I looked at and thought " not ready for prime time "...whoa ...did I F that up

Kiwi
PLTR QBTS QUBT
pos_stock_hoarder pos_stock_hoarder 3 minutes ago
Elephant Revival - Jefferson Airplane "White Rabbit" At Red Rocks Amphitheatre

https://youtu.be/MarQVlEAmBA
Lakota-45 Lakota-45 3 minutes ago
A Notice to the Board; The INQD / Indoor Harvest, Security Details was updated
late yesterday at OTC Markets, Monday, December 16, 2024 !!!
Note: ( No change on the OS ) !!!

~ ( Could it be that Q 1, 2 & 3 will be out - SOON ? )

Note; INQD has been downg
INQD WDLF
Catmandoo Catmandoo 3 minutes ago
Yes, it was a sell, SCAM
HIRU
81vette 81vette 4 minutes ago
Uptrend continues,new highs :-)
BKSY
Tadaaa Tadaaa 4 minutes ago
Hedera HBAR Is Starting To Takeover GLOBALLY (Huge Update)


https://youtu.be/xjwRdLNtX5Y
HBARUSD
paulganade paulganade 6 minutes ago
$mmex interesting volume today 265 Milly
.0001 x .0002
MMEX
Slyhunter Slyhunter 6 minutes ago
Trump is going to keep it up, like Pelosi did for her Husband's Green Energy company.
X
Preciouslife1 Preciouslife1 7 minutes ago
26,750 SHARES = $334,375!!! _____ Heavy Duty Payout for Employees while US Longstanding Shareholders or "Bagholders" get caught up in the "YOU HAVE NO CHOICE GAME OF TENDERED BUYOUT, WITHOUT REBUTTAL!!! ___ EITHER SELL BEFORE AT YOUR FREE WILL CHOICE OR "ACCEPT THE $12.50 BUYOUT PRICE IN THE NEW Y
CDMO
Zardiw Zardiw 8 minutes ago
$OPTX - Gain: 237% #DDAmanda Video Analysis - #1 Stock Screener / Scanner

#DDAmanda Christmas Special Signup:

https://ddamanda.com/SignUpXMAS.php

Questions/Support: 760 702-2009 - Hans@DDAmanda.com

https://www.youtube.com/watch?v=HMH_VK37J
OPTX
Zardiw Zardiw 8 minutes ago
$OPTX - Gain: 237% #DDAmanda Video Analysis - #1 Stock Screener / Scanner

#DDAmanda Christmas Special Signup:

https://ddamanda.com/SignUpXMAS.php

Questions/Support: 760 702-2009 - Hans@DDAmanda.com

https://www.youtube.com/watch?v=HMH_VK37J
OPTX
Zardiw Zardiw 8 minutes ago
$OPTX - Gain: 237% #DDAmanda Video Analysis - #1 Stock Screener / Scanner

#DDAmanda Christmas Special Signup:

https://ddamanda.com/SignUpXMAS.php

Questions/Support: 760 702-2009 - Hans@DDAmanda.com

https://www.youtube.com/watch?v=HMH_VK37J
OPTX
Whalatane Whalatane 8 minutes ago
OK Raggy ...U are forbidden to post here ...U are making to much money ...:--)
Congrats
Kiwi
AMRN
nagoya1 nagoya1 10 minutes ago
Ddddonkey.
Fnma
FNMA
norisknorewards norisknorewards 10 minutes ago
"Maaaaaa, where's the meatloaf!!!!???"
NWBO
axelvento axelvento 12 minutes ago
Immuneering to Present Data from Three Arms of its Ongoing Phase 2a Trial of IMM-1-104 in Early January 2025

https://www.biospace.com/press-releases/immuneering-to-present-data-from-three-arms-of-its-ongoing-phase-2a-trial-of-imm-1-104-in-early-january-2025
IMRX
Whalatane Whalatane 12 minutes ago
DAR53. Well I know U were tempted to buy some AMRN ...but bt QBST instead ...up 77% in the past week ...shame on U :--)
Did Raggy also mention QUBT......dont look at that chart ...don't .

Kiwi
AMRN QUBT
luckydude777 luckydude777 13 minutes ago
Yup. I began watching it after you made a post about it some days back. MUCH APPRECIATED.
norisknorewards norisknorewards 13 minutes ago
Do better, this post sounds like a 17 yo wrote it. Come on, step up, you have to do way much better to drive anyone away
NWBO
Investor082 Investor082 13 minutes ago
Lol, do you expect non dilutive cash before end of Q1 2025? If so, I will put you in the list to send a gentle reminder when LP disappoints and continues to dilute shareholders. ;)
NWBO

Your Recent History

LSE
N4P
N4 Pharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved